Award Winners

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 10%, based on abstract review score, are considered and eligible for a poster presentation award. 
Evaluations of scientific merit were based upon the following criteria:

• Background provides appropriate perspective / context for the subject
• Objectives / research questions are clearly stated
• Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
• Data sources and/or sampling procedures are clear and appropriate
• Data analyses are appropriate
• Research objectives are met/addressed
• Implications of findings are discussed
• Factual information is kept separate from interpretations or implications
• Abstract is presented in an unbiased manner
• Clarity of presentation

THE RECIPIENTS ARE: . . .

ISPOR BEST POSTER RESEARCH PRESENTATION AWARDS

Best General Poster Research Presentations

PPM9: PARTICIPANT SCREENING BEHAVIORS AND INFORMATION SHARING AFTER GENETIC TESTING

Presenting Author: Adriana Boateng-Kuffour, MS, MPH.

Boateng-Kuffour A¹, Zimmer A¹, Chua A², Lai C¹, Ryan L¹, Williams H¹, Zhou A¹

¹Color, Burlingame, CA, USA, ²California State University, Stanislaus, Turlock, CA, USA

PCV30: ESTIMATING HEALTH-STATE UTILITY IN PATIENTS WITH HEART FAILURE: MAPPING THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE TO SF-6D UTILITY SCORES

Presenting Author: Scott Goates, PhD, MS

Goates S¹, Baron SJ², Arnold SV³, Prillinger JB⁴, Cohen D⁵, Spertus JA^6
1Abbott Laboratories, CASTAIC, CA, USA, ²Saint Luke’s Mid America Heart Institute, Kansas City, MO, USA, ³Saint Luke's Mid America Heart Institute, Kansas City, MO, USA, ⁴Abbott Laboratories, Sunnyvale, CA, USA, ⁵Saint Luke’s Mid America Heart Institute/University of Missouri Kansas City School of Medicine, Kansas City, MO, USA, ⁶Saint Luke's Mid America Heart Institute/UMKC, Kansas City, MO, USA

PIH62: ELAGOLIX REDUCES WORK PRODUCTIVITY LOSSES AMONG WOMEN WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH ENDOMETRIOSIS

Presenting Author: Ahmed M Soliman, MS, PhD

Surrey ES¹, Soliman AM², Palac H³, Agarwal SK^4
1Colorado Center for Reproductive Medicine, Lone Tree, CO, USA, ²AbbVie, North Chicago, MA, USA, ³AbbVie Inc., North Chicago, IL, USA, ⁴Center for Endometriosis Research and Treatment, La Jolla, CA, USA

Best Student Poster Research Presentations

PMH49: FACILITY AND STATE-LEVEL FACTORS ASSOCIATED WITH TELEMENTAL HEALTH (TMH) ADOPTION AMONG MENTAL HEALTH FACILITIES IN THE UNITED STATES (US)

Presenting Author: Xiaohui Zhao, MS

Zhao X¹, Bhattacharjee S², Innes K³, LeMasters T⁴, Dwibedi N⁴, Sambamoorthi U^4
1West Virginia University, School of Pharmacy, Boston, MA, USA, ²University of Arizona, Tucson, AZ, USA, ³West Virginia University, Morgantown, WV, USA, ⁴West Virginia University, School of Pharmacy, Morgantown, WV, USA

PCV102: HEALTH RELATED QUALITY OF LIFE OF STROKE SURVIVORS COMPARED TO NON-STROKE INDIVIDUALS AMONG AFRICAN AMERICANS IN THE UNITED STATES: A NATIONALLY REPRESENTATIVE PROPENSITY SCORE MATCHED ANALYSIS

Presenting Author: Arun Kumar, B.Pharm, Pharm.D, MS, PhD Student

Kumar A¹, Wu W^2
1College of Pharmacy, University of Minnesota, Minneapolis, MN, USA, ²College of Pharmacy and Health Sciences, St. John's University, New York, NY, USA

PRO40: ASSOCIATION BETWEEN HYDROXYUREA MEDICATION ADHERENCE AND ALL-CAUSE AND DISEASE-RELATED HEALTHCARE EXPENDITURES AMONG TEXAS MEDICAID ENROLLEES WITH SICKLE CELL DISEASE

Presenting Author: Hyeun Ah Kang, MS, MEd, PhD Candidate

Kang HA¹, Barner JC¹, Rascati K¹, Lawson KA¹, Mignacca R^2
1The University of Texas at Austin, Austin, TX, USA, ²Dell Children’s Blood and Cancer Center, Austin, TX, USA

Best New Investigator Poster Research Presentations

PCV105: EXAMINING THRESHOLDS FOR THE RENIN-ANGIOTENSIN SYSTEM ANTAGONIST MEDICATION ADHERENCE QUALITY MEASURE: THE APPLICATION OF THE LAW OF DIMINISHING RETURNS TO OPTIMIZE ADHERENCE-ASSOCIATED ECONOMIC OUTCOMES

Presenting Author: Patrick J Campbell, PharmD, PhD

Campbell P¹, Malone D², Slack M², Hincapie A³, Warholak T^2
1Pharmacy Quality Alliance, Alexandria, VA, USA, ²University of Arizona, Tucson, AZ, USA, ³University of Cincinnati, Cincinnati, OH, USA

PPM4: COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION SEQUENCING PANEL OF CIRCULATING TUMOR DNA IN THE DIAGNOSIS OF PATIENT WITH METASTATIC NON-SQUAMOUS NON- SMALL CELL LUNG CANCER IN BRAZIL

Presenting Author: Rodrigo Ho, B Pharm

Ho R¹, Sebastião MM², D'Innocenzo M², Nussbaum M^2
1Roche Diagnostics Brazil, S PAULO, SP, Brazil, ²Roche Diagnostics Brazil, São Paulo, Brazil

PCV74: COST REDUCTION AFTER THE INDUCTION OF THE RESIDENT ENLIGHTMENT BASED ON MEDICAL CHECKUP IN A JAPANESE RURAL AREA

Presenting Author: Ayako Shoji, Ph.D

Shoji A¹, Kudo K², Murashita K², Nakaji S², Igarashi A^3
1University of Tokyo, Saitama, 11, Japan, ²Hirosaki University, 5 Zaifucho, Japan, ³University of Tokyo, Tokyo, Japan

Best Podium - General Poster Research Presentations

DM3: QUANTIFYING THE OPPORTUNITY TO REDUCE TOTAL COST OF CARE THROUGH TARGETED MEDICATION PRIORITIZATION AND ADHERENCE IMPROVEMENT IN DIABETES

Presenting Author: Sebastian Schneeweiss, MD, ScD

Schneeweiss S¹, Eapen S², Jan S^3
1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, ²Aetion, Inc, Boston, MA, USA, ³Horizon Blue Cross Blue Shield, Newark, NJ, USA

ND2: COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT

Presenting Author: Daniel Malone, RPh, PhD

Malone D¹, Dean R², Miller B², Arjunji R³, Feltner DE³, Sproule DM³, Jensen IS², Maru B³, Dabbous O^3
1University of Arizona, Tucson, AZ, USA, ²Precision Xtract, Boston, MA, USA, ³AveXis, Inc., Bannockburn, IL, USA

AD3: FOOD INSECURE CANCER SURVIVORS ARE MORE LIKELY TO FORGO OR DELAY MEDICAL CARE

Presenting Author: Jean Mcdougall, PhD

Mcdougall J, Anderson J, Adler Jaffe S, Dailey Y, Meisner A, Sussman A, Guest D, Wiggins C
University of New Mexico, Albuquerque, NM, USA

Best Podium - Student Poster Research Presentations

IN4: REDUCING HOSPITAL-ONSET CLOSTRIDIUM DIFFICILE INFECTION: AN AGENT-BASED MODELING APPROACH TO EVALUATE INTERVENTION COST-EFFECTIVENESS

Presenting Author: Oguz Alagoz, PhD

ON1: UNDERSTANDING VARIATION IN TREATMENT SEQUENCES AND OUTCOMES IN METASTATIC COLORECTAL CANCER: USING REAL WORLD DATA TO ANSWER REAL WORLD QUESTIONS

Presenting Author: Koen Degeling, MSc

Wong HL¹, Degeling K², Jalali A¹, Shapiro J³, Kosmider S⁴, Wong R⁵, Lee B¹, Burge M⁶, Tie J¹, Yip D⁷, Nott L⁸, Khattak A⁹, Lim S¹⁰, Caird S¹¹, IJzerman M¹², Gibbs P^1
1Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, ²University of Twente, Enschede, Netherlands, ³Cabrini Health, Malvern, VIC, Australia, ⁴Western Health, Footscray, VIC, Australia, ⁵Walter and Eliza Hall Institute of Medical Research, Box Hill, Australia, ⁶Royal Brisbane and Women’s Hospital,, South Brisbane, QLD, Australia, ⁷The Canberra Hospital, Garran, ACT, Australia, ⁸Royal Hobart Hospital, Hobart, TAS, Australia, ⁹FIona Stanley Hospital, Murdoch, Australia, ¹⁰Campbelltown Hospital, Campbelltown, NSW, Australia, ¹¹Gold Coast University Hospital, Southport, QLD, Australia, ¹²University of Melbourne, Melbourne, VIC, Australia

TP3: FACTORS ASSOCIATED WITH PRESCRIBING OF ORAL DISEASE MODIFYING AGENTS IN MULTIPLE SCLEROSIS

Presenting Author: Jagadeswara Rao Earla, PharmD, MBA

Earla JR¹, Hutton GJ², Thornton JD¹, Aparasu R^1
1University of Houston, Houston, TX, USA, ²Baylor College of Medicine Medical Center, McNair Campus, Houston, TX, USA

Best Podium - New Investigator Poster Research Presentations

AD4: THE IMPACT OF MEDICARE STAR RATING ADHERENCE MEASURES ON MEDICATION ADHERENCE FOR TARGETED AND NON-TARGETED MEDICATIONS

Presenting Author: Natasha Parekh, MD, MS

Parekh N¹, Munshi K², Hernandez I³, Gellad WF⁴, Henderson R², Shrank WH^5
1UPMC Center for High-Value Health Care, Pittsburgh, PA, USA, ²Express Scripts, Memphis, TN, USA, ³University of Pittsburgh, Pittsburgh, PA, USA, ⁴Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA, ⁵UPMC Insurance Services Division, Pittsburgh, PA, USA

MS3: NEW METHODOLOGIES IN PARAMETRIC NETWORK META-ANALYSES (PNMA): MULTI-ARM CORRECTION FOR RANDOM EFFECTS AND GENERAL POPULATION MORTALITY (GPM)

Presenting Author: Sophie van Beekhuizen, MSc MPhil

van Beekhuizen S¹, van Oostrum I¹, Ouwens DM², Heeg B^1
1Ingress-Health, Rotterdam, Netherlands, ²AstraZeneca, Mölndal, Sweden

MT4: COST UTILITY ANALYSIS UPDATE OF DEEP BRAIN STIMULATION VS. BEST MEDICAL TREATMENT IN THE MANAGEMENT OF PARKINSON DISEASE WITH EARLY MOTOR COMPLICATIONS IN COLOMBIA

Presenting Author: Julian Arcos, BME, MSc, HE

Rueda M¹, Arcos J², Tellez J³, Valencia J^4
1Clinica Soma, Medellin, Colombia, ²Medtronic Colombia, Bogota, Colombia, ³Medtronic Colombia, BOGOTA, CUN, Colombia, ⁴Medtronic, Miami, FL, USA